Final Review | Knowledge Base

Content Status at the final stage of review before it is approved for use.

End TB Strategy Approach

H5Content

Universal Access to Quality TB Care

H5Content

Quality Assurance of Anti-TB Drugs

H5Content

Prevention of Drug-resistance

H5Content

Newer Anti-TB Drugs: Bedaquiline [Bdq]

H5Content

State Airborne Infection Control [AIC] Committee

H5Content

Management of Hepato-toxicity During Treatment with H Mono/Poly DR-TB Regimen

H5Content

Management of Prolonged QTcF During Treatment with Shorter/Longer Oral MDR-TB Regimen

H5Content

Management of QT Prolongation by Grade of Severity of ADR

H5Content

Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment

H5Content

Subscribe to Final Review